ÂÜÀòÂÒÂ×

Mehdi Pabroji is an advisor at AtlasMedx. Mehdi has previously served as the Vice President of Technical Operations and CMC at Sunesis Pharmaceuticals, Inc. from November 2019 to July 2021. Mehdi was responsible for Global Pharmaceutical Development including CMC, Non-clinical, Safety, and Pharmacology, Clinical Supply Management, Project Management, and Inflammation Group and IP/Patent at Biotie Therapies from January 2014 to August 2017. Mehdi also served as the Chief Technical Officer at Valorum Biologics from December 2019 to March 2022. Mehdi is the founder of Lucidus Pharma (Consulting).

Mehdi Pabroji received their PhD in Bio-Organic and Physical Organic Chemistry from The University of Kansas. After completing their PhD, they did a Post-Doc in Pharmaceutical Chemistry at The University of Kansas.